Nurix Therapeutics, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2023 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2023 to Q1 2025.
- Nurix Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending February 28, 2025 was $18.5M, a 11.3% increase year-over-year.
- Nurix Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending February 28, 2025 was $56.4M.
- Nurix Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $54.5M, a 29.1% decline from 2023.
- Nurix Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $77M, a 99.3% increase from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)